Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade-Reference-Cited by-同舟云学术

Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade

Published:2017-04-11 Issue:3 Volume:40 Page:235-246
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Choi Eun-Sun,Oh Sejun,Jang Boonsil,Yu Hyun-Ju,Shin Ji-Ae,Cho Nam-Pyo,Yang In-Hyoung,Won Dong-Hoon,Kwon Hye-Jeong,Hong Seong Doo,Cho Sung-Dae

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s13402-017-0318-8/fulltext.html

Reference54 articles.

1. B. Lujan, S. Hakim, S. Moyano, A. Nadal, M. Caballero, A. Diaz, A. Valera, M. Carrera, A. Cardesa, L. Alos, Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands. Br. J. Cancer 103, 510–516 (2010)

2. S. Schwarz, C. Stiegler, M. Muller, T. Ettl, G. Brockhoff, J. Zenk, A. Agaimy, Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: a clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation. Histopathology 58, 557–570 (2011)

3. M.J. Hicks, A.K. el-Naggar, C.M. Flaitz, M.A. Luna, J.G. Batsakis, Histocytologic grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: a clinicopathologic and flow cytometric investigation. Head Neck 17, 89–95 (1995)

4. M. Guzzo, S. Andreola, G. Sirizzotti, G. Cantu, Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann. Surg. Oncol. 9, 688–695 (2002)

5. E. Vattemi, C. Graiff, T. Sava, R. Pedersini, A. Caldara, M. Mandara, Systemic therapies for recurrent and/or metastatic salivary gland cancers. Expert. Rev. Anticancer. Ther. 8, 393–402 (2008)

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review;Current Medicinal Chemistry;2023-10-26

2. Kaempferol induces apoptosis through the MAPK pathway and regulates JNK-mediated autophagy in MC-3 cells;Toxicological Research;2023-08-11

3. Silybum marianum: An Overview of its Phytochemistry and Pharmacological Activities with Emphasis on Potential Anticancer Properties;Anti-Cancer Agents in Medicinal Chemistry;2023-08

4. Effect of Silibinin on the Expression of Mir-20b, Bcl2L11, and Erbb2 in Breast Cancer Cell Lines;Molecular Biotechnology;2023-03-11

5. Exploiting Vitamin D Receptor and Its Ligands to Target Squamous Cell Carcinomas of the Head and Neck;International Journal of Molecular Sciences;2023-02-28